Lv51
810 积分 2023-11-16 加入
Efficacy and safety of glucagon-like peptide-1 receptor agonist liraglutide in new-onset diabetes after kidney transplantation: An open-label, parallel-group, randomized controlled trial
1个月前
已完结
Efficacy, Mechanisms, and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant Recipients
1个月前
已关闭
The Effect of Adding Dapagliflozin on Chronic Renal Allograft Dysfunction: A Randomized, Prospective, Double-blind, Placebo-controlled Trial
1个月前
已关闭
Randomized Controlled Trial of Dapagliflozin for Post-Transplant Diabetes Mellitus in Renal Transplant Recipients
1个月前
已完结
Intensive monitoring for post-transplant diabetes mellitus and treatment with dipeptidyl peptidase-4 inhibitor therapy
4个月前
已完结
Sitagliptin Might Be a Favorable Antiobesity Drug For New Onset Diabetes After a Renal Transplant
4个月前
已完结
Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation
4个月前
已关闭
Vildagliptin and Pioglitazone in Patients With Impaired Glucose Tolerance After Kidney Transplantation
4个月前
已完结
Efficacy and Safety of Vildagliptin in New-Onset Diabetes After Kidney Transplantation—A Randomized, Double-Blind, Placebo-Controlled Trial
4个月前
已完结
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus
4个月前
已完结
皖公网安备34019202002308
